|
Volumn 63, Issue 9, 2002, Pages 756-757
|
Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 AMINOBUTYRIC ACID;
ALPRAZOLAM;
AMFEBUTAMONE;
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE DERIVATIVE;
BUSPIRONE;
CITALOPRAM;
CLONAZEPAM;
DIAZEPAM;
FLUOXETINE;
LORAZEPAM;
NEFAZODONE;
PAROXETINE;
SEROTONIN;
SEROTONIN AGONIST;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
VENLAFAXINE;
AFFECTIVE NEUROSIS;
ANXIETY NEUROSIS;
DRUG CLASSIFICATION;
DRUG DEPENDENCE;
DRUG INDICATION;
DRUG MECHANISM;
DRUG POTENTIATION;
FEAR;
GABAERGIC SYSTEM;
HUMAN;
MOOD DISORDER;
NEUROANATOMY;
NEUROTRANSMISSION;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
PSYCHOPHARMACOLOGY;
REMISSION;
SEDATION;
SEROTONINERGIC SYSTEM;
SEXUAL DYSFUNCTION;
SHORT SURVEY;
SIDE EFFECT;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
EID: 0036737026
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: 10.4088/JCP.v63n0901 Document Type: Short Survey |
Times cited : (89)
|
References (10)
|